FDA seeks to cut nicotine in cigarettes, tobacco stocks dip following NYT report

Altria and Philip Morris stocks declined after the FDA proposed reducing nicotine in cigarettes. The initiative aims to improve public health but faces significant industry resistance.

Street calls of the week

Earnings call: Altria Group reports growth amid market challenges

Altria reported strong Q3 2024 results with a 7.8% EPS increase, growth in smokable and oral tobacco products, and strategies for modernization despite challenges from the illicit market.

Altria posts better-than-expected Q3 results on robust demand for vapes, nicotine pouches

Altria Group surpassed market expectations with growing demand for its nicotine products and a focus on operational efficiency, despite declining cigarette shipments.

Analysis-Dominating US cigarette sales, a combined 7-Eleven, Circle K would face risk from vapes, cheap smokes